Cargando…
Drug treatment of COVID-19 infection
COVID-19 pandemic has caused more than 6.6 million deaths globally. Tremendous efforts have been committed for the development of new and repurposed drugs for the treatment of COVID-19. Although different international and national guidelines share consensus in the management of COVID-19 disease wit...
Autores principales: | Lui, Grace, Guaraldi, Giovanni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10090306/ https://www.ncbi.nlm.nih.gov/pubmed/36917228 http://dx.doi.org/10.1097/MCP.0000000000000953 |
Ejemplares similares
-
Mass gathering events and transmission of respiratory tract infections: updates pre and post COVID-19 lockdown
por: Hui, David S.C., et al.
Publicado: (2023) -
Nonpharmaceutical interventions for managing SARS-CoV-2
por: Murphy, Caitriona, et al.
Publicado: (2023) -
Effectiveness and safety of coronavirus disease 2019 vaccines
por: Shi, Ting, et al.
Publicado: (2023) -
Airborne transmission of respiratory viruses including severe acute respiratory syndrome coronavirus 2
por: Tang, Julian W., et al.
Publicado: (2023) -
Drug-resistant tuberculosis: advances in diagnosis and management
por: Günther, Gunar, et al.
Publicado: (2022)